Set Your Sights On Dermata Therapeutics Inc (NASDAQ: DRMA)’S Upside Potential
Dermata Therapeutics Inc (DRMA) concluded trading on Thursday at a closing price of $2.48, with 22.51 million shares of worth about $55.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -66.29% during that period and on August 01, 2024 the price saw a […]
Is Dermata Therapeutics Inc (NASDAQ: DRMA) Proving The Doubters Wrong?
Dermata Therapeutics Inc (DRMA) concluded trading on Wednesday at a closing price of $2.67, with 65.11 million shares of worth about $173.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.48% during that period and on July 24, 2024 the price saw a […]
Dermata Therapeutics Inc (DRMA): Insights At A Glance
Acadian Asset Management LLC has recently announced that it has increased stake in Dermata Therapeutics Inc (NASDAQ:DRMA) by 34.21%. After grabbing 75538.0 shares, the institutional investor is now in possession of 19253.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.37% having worth around $56276.0. Moreover, Geode Capital […]
